Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-20 · accession 0001104659-24-025684 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-20 | IOVA | MCPEAK MERRILL A | Dir | P - Purchase | $9.15 | +250.0K | 320.1K | +356% | +$2.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | P | A | 250,000 | $9.15 | 320,150 | D | — | — | (F2) Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024. (F4) Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering. |